Prospective evaluation of prognostic factors uPA/PAI-1 in node-negative breast cancer: Phase III NNBC3-Europe trial (AGO, GBG, EORTC-PBG) comparing 6 × FEC versus 3 × FEC/3 × Docetaxel

BACKGROUND: Today, more than 70% of patients with primary node-negative breast cancer are cured by local therapy alone. Many patients receive overtreatment by adjuvant chemotherapy due to inadequate risk assessment. So far, few clinical trials have prospectively evaluated tumor biology based prognos...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Kantelhardt, Eva J, Vetter, Martina, Schmidt, Marcus, Veyret, Corinne, Augustin, Doris, Hanf, Volker, Meisner, Christoph, Paepke, Daniela, Schmitt, Manfred, Sweep, Fred, von Minckwitz, Gunter, Martin, Pierre-Marie, Jaenicke, Fritz, Thomssen, Christoph, Harbeck, Nadia
التنسيق: Artigo
اللغة:Inglês
منشور في: BioMed Central 2011
الموضوعات:
Study Protocol
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC3089797/
https://ncbi.nlm.nih.gov/pubmed/21496284
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-11-140
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة